title: 2013 American Thoracic Society International Conference.
authors.forename: Farhat
authors.initials: F
authors.lastname: Yaqub
mesh_terms: D018712:Analgesics, Non-Narcotic / Q000009:adverse effects; D001249:Asthma / Q000139:chemically induced; D001549:Benzamides / Q000627:therapeutic use; D002991:Clofazimine / Q000627:therapeutic use; D003226:Congresses as Topic; D003503:Cyclobutanes / Q000627:therapeutic use; D004338:Drug Combinations; D006024:Glycopyrrolate / Q000031:analogs & derivatives / Q000627:therapeutic use; D017052:Hospital Mortality; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D007362:Intensive Care Units / Q000706:statistics & numerical data; D008168:Lung / Q000166:cytology; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy; D015363:Quinolones / Q000627:therapeutic use; D012955:Societies, Medical; D013896:Thoracic Diseases; D016896:Treatment Outcome; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy; D014481:United States; D000515:alpha 1-Antitrypsin / Q000627:therapeutic use; D019896:alpha 1-Antitrypsin Deficiency / Q000188:drug therapy
chemical_list: C516686:2-hydroxy-N,N-dimethyl-3-(2-((1-(5-methylfuran-2-yl)propyl)amino)-3,4-dioxocyclobut-1-enylamino)benzamide; D018712:Analgesics, Non-Narcotic; D001549:Benzamides; D003503:Cyclobutanes; D004338:Drug Combinations; D007189:Indans; D015363:Quinolones; D000515:alpha 1-Antitrypsin; C554862:indacaterol-glycopyrronium combination; D002991:Clofazimine; D006024:Glycopyrrolate